Product Information
METRONIDAZOLE 500 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1012 per EA under NDC 62135079690. Its NADAC has been published 124 times since Apr 10, 2024.
FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Chartwell RX LLCNDC
62135079690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205245FDA Approved
9/23/2015
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 500 MG TABLET has been published 124 times since Apr 10, 2024, and over the history we have for it it has declined 23.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1012 per EA |
|---|---|
| All-time high | $0.1314 (Apr 10, 2024) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1094 |
| 52-week low | $0.0999 |
| Median price | $0.1024 |
| Average price | $0.1029 |
| Largest weekly change | +39.1% (Jun 19, 2024) |
| Weeks tracked | 124 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 500 MG TABLET, manufactured by Chartwell RX LLC, is $0.1012 per EA (NDC 62135079690), effective Aug 19, 2026.
How has the price of METRONIDAZOLE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 500 MG TABLET has declined 23.0%. It has been tracked across 124 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 500 MG TABLET?
Since Apr 10, 2024, the NADAC for METRONIDAZOLE 500 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.1314 (Apr 10, 2024), with a median of $0.1024 per EA.
Are there cheaper alternatives to METRONIDAZOLE 500 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 500 MG TABLET?
METRONIDAZOLE 500 MG TABLET (NDC 62135079690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.